Fig. 3

ROC analysis suggests FFAR4 is valuable molecular biomarker for LUAD. A ROC curves indicated that FFAR4 expression was a valuable indicator of the difference between tumors and normal tissues. The X- and Y-axis correspond to rates of true- and false-positive results, respectively. B–E Subgroup analyses for stage I, II, III, and IV LUAD tumors